Google News – EMA (biotech/pharma) External News
Biotechnology Articles
Google News – EMA (biotech/pharma) External News
Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo Finance
Google News – EMA (biotech/pharma) External News
Sun Pharma partner Philogen resubmits Nidlegy application in Europe - pharma.economictimes.indiatimes.com
Google News – Biotech Funding External News
From confidence to capital: Positioning biotech for the next growth cycle - BioPharma Dive
Google News – Clinical Trials External News
Breaking the taboo on including pregnant women in vaccine clinical trials - PATH
Google News – FDA (biotech/pharma) External News
On 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD - Fierce Pharma
Google News – EMA (biotech/pharma) External News
European launch: Manufacturing as cornerstone for success - pharmaphorum
Google News – Biotech Funding External News
Denmark’s foundation‑fueled biotech boom redraws the Nordic map - BioSpace
Google News – Biotech Funding External News
INTERVIEW: 'The EU’s Biotech Act is helpful, but not yet the solution,' investors say - euractiv.com
Google News – FDA (biotech/pharma) External News
AbelZeta Receives FDA Clearance of Registrational Phase II Trial for C-CAR168 in Refractory Lupus Nephritis - PR Newswire
Google_site External News
Chinese biotech overtakes AI as emerging-market growth trade - The Business Times
Google News – EMA (biotech/pharma) External News
Atossa Therapeutics (ATOS) Gains 4.6%: Biotech Stock Tests Key Resistance - Triple EMA - vinanet.vn
Google News – FDA (biotech/pharma) External News
The FDA was all in on AI. Will that change? - Pharma Voice
Google News – FDA (biotech/pharma) External News
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback - Fierce Pharma
Google News – EMA (biotech/pharma) External News